Comparison · NCT01226459-sae
Minoxidil Foam vs Vehicle Foam: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Minoxidil Foam vs Vehicle Foam: serious adverse events. Trial comparisons, record NCT01226459-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01226459-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0296 | 0.0136 | 0.063 | wilson | |
| Risk in group 2 | 0.0199 | 0.00777 | 0.05 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00966 | -0.0244 | 0.0452 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.49 | 0.426 | 5.18 | log | |
| Odds ratio, group 1 over group 2 | 1.5 | 0.417 | 5.4 | log | |
| Number needed to harm, for one more participant with a serious adverse event on Minoxidil Foam than on Vehicle Foam | 104 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: vehicle.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Minoxidil Foam | 5% Minoxidil Topical Foam~5% Minoxidil Topical Foam: Dosage Form: 5% Minoxidil Topical Foam applied to the scalp; Dosage: half a cap, equivalent to 1 g of foam; Frequency: once every day; Duration: 24 weeks | 6 | 203 | EG001 |
| Group 2 | Vehicle Foam | Vehicle Topical Foam~Vehicle Topical Foam: Dosage Form: Vehicle Topical Foam applied to the scalp; Dosage: half a cap, equivalent to 1 g of foam; Frequency: once every day; Duration: 24 weeks | 4 | 201 | EG000 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
Source ClinicalTrials.gov
Trial
- Title
- Clinical Trial in Females for Female Pattern Hair Loss
- NCT number
- NCT01226459
- Phases
- PHASE3
- Conditions
- Androgenetic Alopecia
- Interventions
- 5% Minoxidil Topical Foam, Vehicle Topical Foam
- Lead sponsor
- Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.
- Results first posted
- 2014-06-03
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01226459?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01226459-sae